|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1996)) |
| Is prodrug? | Yes |
| Active form | phenytoin |
IUPAC Name ![]() |
| [(2-hydroxy-5-oxo-4,4-diphenyl-4,5-dihydro-1H-imidazol-1-yl)methoxy]phosphonic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6484 | fosphenytoin |
Synonyms ![]() |
| ACC-9653-010 |
| Cerebyx® |
| CI-982 |
Database Links ![]() |
|
| CAS Registry No. | 93390-81-9 |
| ChEMBL Ligand | CHEMBL1201336 |
| DrugBank Ligand | DB01320 |
| PubChem CID | 56339 |
| Search Google for chemical match using the InChIKey | XWLUWCNOOVRFPX-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | XWLUWCNOOVRFPX |
| Search PubMed clinical trials | fosphenytoin |
| Search PubMed titles | fosphenytoin |
| Search PubMed titles/abstracts | fosphenytoin |
| Wikipedia | Fosphenytoin |
| Comments |
| Fosphenytoin is a prodrug of phenytoin. This drug is an anticonvulsant. Marketed formulations may contain fosphenytoin sodium (PubChem CID 56338). |